A detailed history of Von Borstel & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Von Borstel & Associates, Inc. holds 959 shares of LLY stock, worth $809,654. This represents 0.29% of its overall portfolio holdings.

Number of Shares
959
Previous 949 1.05%
Holding current value
$809,654
Previous $840,000 11.9%
% of portfolio
0.29%
Previous 0.48%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$727.2 - $932.06 $7,272 - $9,320
10 Added 1.05%
959 $740,000
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $732,760 - $911,058
949 New
949 $840,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Von Borstel & Associates, Inc. Portfolio

Follow Von Borstel & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Von Borstel & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Von Borstel & Associates, Inc. with notifications on news.